Skip to main content

minicounsel

Dr. Ron Dagan

DD

Intellectual Property Law

Dr. Ron Dagan

Distinguished Professor of Pediatrics and Infectious Diseases, Ben-Gurion University of the Negev

Since 2021

1

cases · 1 yrs · FC

Trial

Motion

Costs

Appeal

Sentencing

1 total

Steven G. Mason

In Private Practice18 cases1995–2021

Sharanya Thavakumaran

In Private Practice7 cases2018–2025

Shantelle Lafayette

0 cases2021–2021

Sarit Esther Batner

In Private Practice79 cases2000–2026

Richard Lizius

In Private Practice13 cases2014–2025

Rebecca Crane

In Private Practice2 cases2021–2021

Orestes Pasparakis

In Private Practice50 cases2003–2026

Morgan Westgate

Practising Law - Employed5 cases2017–2022

Laura E. MacDonald

0 cases2021–2021

Jonathan Chong

0 cases2021–2021

Joanne Chriqui

0 cases2021–2021

Fortunat Nadima Nadima

0 cases2021–2021

Fiona Legere

In Private Practice6 cases2013–2026

Edwin Mok

0 cases2021–2021

Christopher A. Guerreiro

1 case2021–2023

Andrea Campbell

In Private Practice8 cases2014–2022

Amy Grenon

In Private Practice1 case2021–2024

Jocelyne Gagné

FC16 cases2020–2023

FCFederal CourtApr 30, 2021

Federal Court

Federal Court

Composition patent for Prevnar 13 upheld; formulation patents invalidated for obviousness.

Merck sought to impeach Wyeth's composition and formulation patents relating to the Prevnar 13 pneumococcal conjugate vaccine.

The Court found that the composition patent claims were valid but limited to 13 serotypes, as the invention was neither anticipated nor obvious given the complexities of conjugation and immune interference.

However, the Court invalidated the formulation patents, finding that the use of surfactants, buffers, and aluminum salts to stabilize formulations in siliconized containers was obvious in light of prior art, and the specific 13-valent claims were invalid for obviousness-type double patenting.

Merck Sharp & Dohme Corp. v. Wyeth LLC, 2021 FC 317

Distinguished Professor of Pediatrics and Infectious Diseases, Ben-Gurion University of the Negev · development of pneumococcal vaccines, serotype selection, immune interference · Retained by Respondent

Lawyers who appeared with Dr. Ron Dagan

Steven G. Mason

1

1

1

1

Laura E. MacDonald

1

Sharanya Thavakumaran

1

Orestes Pasparakis

1

1

1

Christopher A. Guerreiro

1

Andrea Campbell

1

Morgan Westgate

1

1

Fortunat Nadima Nadima

1

Shantelle Lafayette

1

Sarit Esther Batner

1

Judges who heard Dr. Ron Dagan's testimony

Jocelyne Gagné

1

total cases

1 yr

active span

1

court

1.0

cases/mo

FC1(100%)

Retained by

Respondent

1

Case types

application

1